logo
Health facilities are still not functioning at full capacity to manage diabetes and hypertension, study finds

Health facilities are still not functioning at full capacity to manage diabetes and hypertension, study finds

The Hindu2 days ago

Public Primary Health Centres (PHCs) are better prepared for diabetes and hypertension care than Sub-Centres, Community Health Centres (CHCs), and Sub-District Hospitals, a study undertaken by the Indian Council of Medical Research-National Centre for Disease Informatics and Research (ICMR-NCDIR), Bengaluru has found.
A cross-sectional survey of health facilities was conducted in 19 districts of seven States in India, which included an assessment of both public and private health facilities.
India has the second highest number of adults with diabetes in the world, and more than one-fourth of adults have hypertension. The study was undertaken to assess 'preparedness of public & private health facilities for management of diabetes & hypertension in 19 districts in India''.
It found that the overall readiness score for providing hypertension and diabetes services was lowest for Sub-Centres (61%), and CHCs (59%), when compared with other facilities.
The readiness score for public PHCs, and private primary care facilities (level 2) was 73% and 57%, respectively. The readiness score of district hospitals, government private medical colleges, and other private tertiary care facilities was above 70%, and they were considered prepared for services.
The study found that out of the 415 health facilities covered in the survey, 75.7% were public facilities. More than half (57.6%) were primary care facilities, and 53.3% of them were situated in rural areas.
Experts have now recommended ensuring the availability of adequate human resources, uninterrupted supply of essential medicines, and programme managers for all public health facilities, to ensure full utilisation of healthcare centres for diabetes and hypertension care.
'Diagnostic services were less available at district hospitals, indicating that secondary higher-level public health facilities were not fully prepared to manage complications of these two conditions. Efforts to strengthen diagnostic services are essential for the continuum of care, as there will be in-referrals of patients from peripheral public health facilities to District Hospitals,'' the study said, adding that work must be done to ensure a reliable drug supply, and accurate information systems in primary healthcare facilities.
Equipment, medicines, diagnostics capacity, staff, the availability of guidelines, and overall readiness score was calculated following the World Health Organization's SARA (Service Availability and Readiness Assessment) manual.
The study was conducted in two-phases — the first phase was conducted from September 15, 2021 to December 15, 2021, and the second phase from February 1, 2023 to June 30, 2023.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

COVID-19: Active cases cross 4,000 mark
COVID-19: Active cases cross 4,000 mark

Time of India

time11 hours ago

  • Time of India

COVID-19: Active cases cross 4,000 mark

New Delhi: India's active COVID-19 cases have crossed the 4,000 mark, with Kerala remaining the most affected state followed by Maharashtra, Gujarat, and Delhi, according to the Union Health Ministry data released on Tuesday. There are 4,026 active cases in India and five fresh deaths have been reported in the last 24 hours. Since January this year, 37 deaths have been reported in the country. There were 257 active patients in the country on May 22. The figure rose to 3,395 by May 31 and subsequently to 4,026 cases. Presently, Kerala has 1,446 active cases, the highest in the country followed by Maharashtra with 494, Gujarat with 397 and Delhi with 393 cases. Five deaths, one each in Kerala, Tamil Nadu and West Bengal and two deaths in Maharashtra, have been reported in the last 24 hours, according to the data. Official sources on May 31 stated that the COVID-19 situation in India is being closely monitored while stressing that the severity of infections is low, with most of the patients being under home care and that there was no cause for worry. Director General of Indian Council of Medical Research (ICMR) Dr Rajiv Behl on Monday stated that genome sequencing of samples in West and South have shown that the variants leading to the current rise in cases are not severe and are subvariants of Omicron only. The four variants that we have found are subvariants of Omicron,, LF.7, XFG, JN.1 and NB. 1.8.1. The first three have been found in more number of cases, he said. "We have been closely monitoring the situation. At this moment overall, we should monitor, be vigilant but there is no cause to worry," Dr Behl had said.

Government plans to wind down National Polio Surveillance Network centres in India
Government plans to wind down National Polio Surveillance Network centres in India

The Hindu

time11 hours ago

  • The Hindu

Government plans to wind down National Polio Surveillance Network centres in India

The government has proposed to wind down, in phases, the World Health Organization (WHO)-established National Polio Surveillance Network (NPSN), currently a countrywide network of over 200 units. Experts in the field have commented that the move would be premature and ill-advised at this stage, with India's neighbouring countries still harbouring cases of polio. Staff at the NPSN centres have received a communication from the WHO's representative in India, Roderico H. Ofrin, advising them of an upcoming transition initiated by the government. The transition involves a gradual drawdown of the NPSN units each year — from approximately 280 units in 2024-25 down to 190 in 2025-26, and further to 140 in 2026-27. This is also linked with a corresponding reduction in financial support from the government, according to the communique. The process of transition will begin in June. 'We are not disbanding teams overnight or winding down the network haphazardly; rather, specific units will phase out at set intervals as government systems ramp up and absorb these functions,' Dr. Ofrin said. This will help us ensure that, at any given time, critical surveillance activities continue with minimal or no gaps, he said. While he assured the staff of the NPSN that this would help retain critical surveillance activities, at some point, polio surveillance would be subsumed within the Integrated Diseases Surveillance Programme. But the proposed winding down of a key unit, at a time when global resurgence of polio has been reported, has not gone down well, with either staffers or public health experts. India was declared polio-free in 2014, after three years of no case caused by wild polio virus transmission. The gains came after a full-frontal attack launched on polio, through years of coordinated work and oral polio immunisation campaigns, with a number of organisations collaborating. Jacob John, prominent virologist and vaccine expert, who has been actively involved in polio eradication efforts, including as a member on the National Technical Advisory Group on Immunisation, said he was 'horrified' by the move. 'The world has lots of polio still. It is way too early to upset our current 'steady state',' he added. He pointed out that Afghanistan and Pakistan continued to have polio cases, and that it is too close for comfort, also pointing to the danger of vaccine-derived polio virus. 'For every type 1 wild virus polio in Pakistan, there are about 10-12 circulating vaccine-derived poliovirus polio cases, mostly type 2, globally. After April 2016, we have not immunised children against type 2. In case vaccine derived polio virus is imported into India, widespread transmission and polio cases by the dozen are expected,' Dr. John said. A long-time campaigner for injectable polio vaccines (IPVs), Dr. John suggests that India should first replace oral polio vaccine (OPV) with IPV. After one year, all OPV can be withdrawn. Then, one year later, we can look at dismounting the watch. 'If surveillance is diluted now, we become sitting ducks for the resurgence of polio due to circulating VDPV, type 2 most likely, and type 1 less likely,' Dr. John said. Dr. Ofrin's letter also touches upon job security for existing staff, but the polio surveillance medical officers in the country under the Special Services Agreement, said it's not at all reassuring. 'Each centre has at least four employees. Imagine the number of people who won't have a job,' one doctor said, speaking on condition of anonymity. He also said that, since 2014, the NPSN had been functioning as a unit of the Central government, which expanded the role of the staff to conduct surveillance for measles and rubella, DPT (diphtheria, pertussis or whooping cough, and tetanus), child vaccination, and training the health workforce every time a new vaccine was introduced. He pointed out that there seemed to be no rationale in shutting down these particular centres. 'Vaccine-preventable diseases are a critical area; the country's progress should not be compromised at this stage,' he said.

Work on BSL-3 virus research lab in Kozhikode progressing at a slow pace
Work on BSL-3 virus research lab in Kozhikode progressing at a slow pace

The Hindu

time15 hours ago

  • The Hindu

Work on BSL-3 virus research lab in Kozhikode progressing at a slow pace

The work on a biosafety level-3 (BSL-3) Virus Research and Diagnostic Laboratory is progressing at a slow pace at the Government Medical College Hospital, Kozhikode. The authorities are hopeful that it will be completed by the year-end. The proposal to upgrade the existing BSL-2 Virus Research and Diagnostic Laboratory under the State government to a regional-level lab was made after the Nipah outbreak in Kozhikode in 2018. As the regional lab should have BSL-3 standards, it was proposed to enhance the existing system there. According to sources, the Indian Council of Medical Research (ICMR) allocated ₹5.5 crore for the project in 2019. The estimate was later revised to ₹8 crore. The official process for the purpose was halted in the wake of the COVID-19 pandemic. The work began only in November 2021. Research on low-risk microbes is carried out at a BSL-1 lab and infectious organisms affecting humans can be dealt with at a BSL-2 lab. Indigenous or exotic microbes are handled at a BSL-3 lab, while deadly organisms require a BSL-4 lab. The sources said that the work is undertaken by the Central Public Works department. One of the reasons for the delay was a dispute between the contractor and the department, following which another contractor was assigned the work. It is learnt that the equipment for the lab is being purchased through Kerala Medical Services Corporation Ltd. A senior hospital official said on Tuesday (June 3) that the work could be completed by the end of this year, provided there were no further obstacles. At present, the body fluid samples of patients suspected to be suffering from highly infectious diseases such as Nipah are being sent to the National Institute of Virology, Pune, for confirmation tests. Once the lab is fully functional after getting the approval from the ICMR, such tests can be done here. Health Minister Veena George had said in the Assembly last year that the lab would become fully functional by 2027.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store